Autres langues Synairgen plc

Actions

Temps Différé London S.E. Autres places de cotation 13:31:21 30/04/2024			Varia. 5j.	Varia. 1 janv.
6,432 ^GBX	-1,05 %		-8,38 %	+7,65 %

2023	Synairgen nomme Joseph Colliver, de Phytome, au poste de directeur financier	AN
2023	La société de biotechnologie Synairgen nomme un nouveau directeur financier	MT

Synairgen : IDWeek 2023 Poster Presentation	12/10/23
FTSE 100 Finishes Slightly Lower After Steady Session	11/10/23
Synairgen names Phytome's Joseph Colliver as CFO	11/10/23
Biotech Company Synairgen Names New CFO	11/10/23
Synairgen plc Announces Executive Changes	11/10/23
Synairgen plc Announces Board Changes	11/10/23
Synairgen promotes Marcin Mankowski to chief medical officer	03/10/23
Synairgen plc Announces Appointment of Dr. Marcin Mankowski as Chief Medical Officer	03/10/23
Synairgen narrows interim loss on reduced R&D spending	21/09/23
Synairgen looking beyond COVID in fight against respiratory illness	21/09/23
Synairgen : Interim Results	21/09/23
Earnings Flash (SNG.L) SYNAIRGEN Posts H1 Loss GBX-2.36	21/09/23
Synairgen plc Reports Earnings Results for the Half Year Ended June 30, 2023	21/09/23
Synairgen : ATS 2023 SPRINTER Poster Presentation	23/05/23
Synairgen : 2022 Annual Report	23/05/23
Synairgen CEO lays out plans for 2023 and beyond	28/04/23
Synairgen loss narrows; aims to develop SNG001	27/04/23
Earnings Flash (SNG.L) SYNAIRGEN Reports FY22 Loss GBX-8.76	27/04/23
Synairgen plc Reports Earnings Results for the Full Year Ended December 31, 2022	27/04/23
TRADING UPDATES: SulNOx raises funds; Synairgen shares trial results	23/12/22

Aucun résultat pour cette recherche